NEW YORK (GenomeWeb) – Shuwen Biotech announced today that it has received CE-IVD marking for its real-time PCR-based EGFR detection kit for lung cancer.

According to the company, the kit detects 29 mutations in exons 18, 19, 20, and 21, and has a limit of mutation detection at .1 percent in a background of wild-type DNA. It also contains lyophilized reagents that can withstand at least 12 freeze/thaw cycles.

With the CE-IVD marking, the kit is now approved for sale throughout the European Economic Area.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.